OCA Ventures — 2023 Investments
9 investments dated 2023 · listed companies and verified rows first · show all
Amplified Sciences is a clinical-stage diagnostics company that has developed an ultra-sensitive optical reporter platform for multi-omics diagnostic tests, aimed at helping clinicians detect, treat, and monitor difficult diseases.
BiotechHealthtechMedical DevicesWest Lafayette, US
Diana Caldwell(Executive Officer, Director)inVincent Jo Davisson(Executive Officer, Director)
BoardAndrew Cothrel(Director)inWade Lange(Director)Robert Saunders(Director)
Co-investorsBeni Venture CapitalElevate VenturesGravity VenturesHouston Angel NetworkIU VenturesFlywheel Fund
Atalan Tech develops clinician retention intelligence solutions for healthcare systems and organizations seeking to identify at-risk clinicians early, understand underlying causes of burnout and turnover, and implement targeted interventions to improve workforce sustainability.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechHR TechCalifornia, US
Tiffany ChaninSisi HuinTim Russo(Senior Healthcare Technology Executive)inSteven Strongwater(Director)Bob Saunders(Director)B. Bobby Bahram(Director)
Co-investorsBioAdvanceBroad Street AngelsEarly Light VenturesExcelerate Health VenturesVTC Ventures
Betty is a real-money online casino operator combining iCasino gaming with casual mobile game mechanics for Canadian players.
Co-investors359 CapitalCourtside VenturesGaingelsVelo Partners305 VenturesKarlani Capital+1 more
Hubly is a workflow management and business operations platform for financial advisory firms that enables advisors to manage client relationships, business operations, and complex processes in a single system.
Enterprise SoftwareFintechHealthtechSaaSVancouver, CA
Louis Retief(Co-founder)inRon Gorodetsky(Co-founder)inCasey Qadir(Executive Officer, Director)Casey Mimi Grage(Executive Officer, Director)
BoardNancy Harvey(Director)Mark Fisher(Director)
Co-investorsLong Way VenturesTechstarsCascade Seed FundMucker Capital
Pair Team operates a medical group and is building an AI-based care manager for complex, low-income patients covered by Medicaid, Medicare, and public assistance programs, addressing clinical, behavioral, and social needs such as housing, food, and transportation.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Neil Batlivala(Founder)inCassie Choi(Founder)inCassandra Choi(Executive Officer, Director)inAndres Calabrese(Engineer)Lucas Cook(Software Engineer)Lori Sparks(Recruiting)
Co-investorsAlix VenturesAugment VenturesCraft VenturesCREATE HEALTH VENTURESGaingelsHead & Heart Capital+18 more
Pioneering the development of prescription digital therapeutics.
HealthtechBoston, US
Corey McCann(Executive Officer, Director)inAntoun Nabhan(Executive Officer)Christopher Guiffre(Executive Officer)
BoardAndrew Schwab(Director)inTimothy Petersen(Director)inZack Lynch(Director)in
Co-investorsJAZZ Venture Partners5AM VenturesArboretum VenturesGeneral CatalystSeyen CapitalSoftBank Group+2 more
PursueCare provides addiction treatment and mental health services designed to increase accessibility to comprehensive care.
Digital HealthHealthtechMental HealthMiddletown, US
Nicholas Mercadante(CEO & Founder)inEd Mercadante, RPh, ScD(Co-Founder)Thomas Menighan, R.Ph, Sc.D(Co-founder)in
Co-investorsAdvection Growth CapitalConnecticut InnovationsSeyen CapitalYamaha Motor Ventures
T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.
BiotechDigital HealthMedical Devices
Kwesi Frimpong-Boateng(Co-founder & Managing Partner)inMichael Langer(Co-founder & Managing Partner)inCorey M. McCann(Co-founder & Managing Partner)inRobert Langer(Executive Chairman & Chair of Scientific Advisory Board)
Co-investorsModi VenturesSeyen CapitalYamaha Motor Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















__Twitter.png)





















.png)






